Is There a Single “Best” Platform or Will it be “Fit to Purpose”?

Time: 5:45 pm
day: Day One


• Analysing the advantages, disadvantages and comparisons of the DNA, Peptide, RNA, and Virus-based and other novel vaccine platforms
• Harmonisation of clinical outcomes and immune correlates
• Considering if we can we get better at predictive animal models?
• Questioning what other signals we need to provide to the immune system, either built into the vaccine or given concomitantly (checkpoints, costims, cytokines, innate immunity boosters, etc.)